Published April 3, 2026
| Version v1
Report
Open
Molecular Mechanisms of Stem Cell Pluripotency and Self-Renewal: From Core Networks to Clinical Translation
Authors/Creators
Description
This in-depth technical review synthesizes the current understanding of the molecular mechanisms underpinning stem cell pluripotency and self-renewal, bridging foundational biology with advanced clinical applications. At the core of pluripotency is a robust transcriptional network orchestrated by OCT4, SOX2, and NANOG. These factors operate through complex autoregulatory and feedforward loops to suppress differentiation and maintain the stem cell state. This network is tightly integrated with extrinsic signaling pathways, notably LIF/STAT3 in naive murine embryonic stem cells (ESCs) and TGF-β/Activin/Nodal in primed human ESCs, which coordinate cell fate decisions.
The article highlights the profound epigenetic and metabolic reprogramming required to establish and sustain pluripotency. Epigenetic controls, including dynamic DNA methylation and bivalent histone modifications (H3K4me3 and H3K27me3), act as molecular switches that preserve multilineage potential. Concurrently, a critical metabolic shift from oxidative phosphorylation to aerobic glycolysis supports the anabolic demands of rapid proliferation and provides essential cofactors for epigenetic enzymes. The review also explores the unique cell cycle dynamics of ESCs, specifically their abbreviated G1 phase, which minimizes exposure to differentiation signals.
Methodological innovations are a major focus, detailing transcription factor-mediated and chemical reprogramming strategies for generating induced pluripotent stem cells (iPSCs). The text evaluates advanced experimental techniques, such as single-cell RNA sequencing, CRISPR-based molecular recording, and high-content screening, which are revolutionizing lineage tracing and disease modeling.
Finally, the review addresses the clinical translation of stem cell technologies in regenerative medicine. While iPSCs offer unprecedented opportunities for patient-specific therapies and drug discovery, significant hurdles remain. These include overcoming epigenetic memory, mitigating tumorigenic risks associated with the p53 pathway and residual undifferentiated cells, and standardizing differentiation protocols to reduce population heterogeneity. By providing a strategic framework for optimizing stem cell technologies, this guide serves as a vital resource for researchers striving to develop safe and effective cell-based therapies.
Source: https://www.stemcellbiosci.com/posts/molecular-mechanisms-of-stem-cell-pluripotency-and-selfrenewal-from-core-networks-to-clinical-translation